KPMG Global tech report 2026: Life Sciences

Unlocking value in an era of widespread tech adoption

Life Sciences technology leaders largely see themselves as innovators or fast followers, adopting new tools once proven or leading selectively where the business case is clear. Companies in the sector have moved beyond experimentation and into broad adoption of core technologies such as AI, data analytics and cybersecurity. However, while digital investment is widespread, value realisation remains constrained.

Key findings from our research

KPMG Global tech report 2026: Life Sciences

A snapshot on technology adoption, investment, and value realisation

Download the report

For India, these findings signal a clear shift from pilots to scale, where success will hinge on strengthening data and cloud foundations, backing fewer high-impact bets, and converting AI adoption into measurable, enterprise-wide value. They also reinforce the need to bridge the gap between innovation and impact by industrialising digital capabilities and embedding governance-led execution.

Vijay Chawla

Partner and Chief Operating Officer – Consulting and Head, Life Sciences

KPMG in India

Why download the report?

By downloading Global tech report 2026: Life Sciences, you will:

Learn where Life Sciences companies are really winning with technology – and where they aren’t
Explore the value capture gap and practical guidance on how to close it
Gain executive-ready insights that help to support sharper decision-making on where to invest, scale or stop

Download the report

About the research

The insights in this report were derived from the KPMG Global Tech Report 2026, a survey of 2,500 technology leaders from 24 countries across eight industries, Life Sciences included. Survey respondents represented organisations with annual operating budgets or revenues above US$100 million and included a diverse group of technology leaders, such as chief data or digital officers, CIOs, CTOs, CISOs, chief AI officers and others.

The Life Sciences insights are based on the views of 124 Life Sciences technology function leaders.